Skip to content
Trial Eligibility
Menu

Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics

NCT03215836

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The objective of this pilot study is to determine whether obesity and metabolic syndrome are in fact synergistic in relation to airway nitric oxide (NO) biology. To do so, the investigators want to determine how obesity and the metabolic syndrome relate to metabolism in bronchial airway epithelial cells and the nasal epithelium.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Asthma
  • Obesity
  • Metabolic Syndrome

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 65 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Colorado, Denver
Last updated on ClinicalTrials.gov
February 2, 2023

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • University of Colorado · Aurora, CO

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.